Indegene has appointed Jill DeSimone to its Board of Directors.

P. gingivalis, a type of bacteria found in the mouth, is linked to autoimmune diseases like rheumatoid arthritis ...

Awards has hosted the inaugural EHP Awards presentation and dinner that included an exclusive networking event and panel ...

Cuttsy+Cuttsy announces its transition to employee ownership, celebrating 15 years of prioritising clients, patients, and its team while continuing under the leadership of founders Caroline Benson and ...

Approximately 70% of metastatic triple-negative breast cancer patients are ineligible for immunotherapy, creating an unmet ...

If we don’t have compassion, we really do need to question what that says about us as individuals and organisations ...

Gastric cancer is the fifth highest cause of cancer deaths worldwide, with almost a million people diagnosed annually ...

Union Chimique Belge (UCB) has announced the release of new positive data regarding Bimzelx (bimekizumab) in moderate to ...

ASH 2025 showed up with a clenched fist and never loosened it. Under the rallying call of ‘Fight 4 Hematology’, the meeting ...

McNamara’s Fallacy is the error of making decisions based solely on easily quantifiable data, while ignoring ...

Turn interaction into intelligence! Don’t miss this chance to lead the industry with our free pharma-exclusive webinar!

Spyre Therapeutics has appointed Kate Tansey Chevlen as Chief Commercial Officer.